netFormulary Berkshire West NHS NHS
Royal Berkshire NHS Foundation Trust
Berkshire Healthcare NHS Foundation Trust
Berkshire West Clinical Commissioning Group
 
 Search
 Formulary Chapter 8: Malignant disease and immunosuppression - Full Chapter
Notes:
This formulary is used by multiple organisations. There may be some instances where an item is on the formulary for one organisation but not the others. To help distinguish between each organisation, text will be colour coded, i.e. information relating to the Royal Berkshire NHS Foundation Trust will be in blue and Berkshire Healthcare NHS Foundation Trust will be in purple. Please ensure you read all information detailed under a drug.   
Chapter Links...
 Details...
08.03.04.02  Expand sub section  Prostate cancer and gonadorelin analogues
08.03.04.02  Expand sub section  Gonadorelin analogues
08.03.04.02  Expand sub section  Anti-androgens
Leuprorelin Acetate (Prostap® 3, Prostap® SR)
View adult BNF View SPC online View childrens BNF  Track Changes
First Choice
Amber
Royal Berkshire NHS Foundation Trust >> Formulary Item injection
 
Abiraterone Actetate  (Zytiga®)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red
High Cost Medicine

note NHS England Commissioning requirements for funding apply prior to use. Please contact pharmacy for details prior to prescribing this item.

Royal Berkshire NHS Foundation Trust >> Formulary Item tablets
Restricted Item ONLY in line with NICE TA - link below

Berkshire Healthcare NHS Foundation Trust >> NON - Formulary Item - contact pharmacy for advice

 
Link  NICE TA 259 - Abiraterone for castration-resistant metastatic prostate cancer previously treated with a docetaxel-containing regimen
Link  NICE TA 387 - Abiraterone for treating metastatic hormone-relapsed prostate cancer before chemotherapy is indicated
   
Bicalutamide
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Amber
Royal Berkshire NHS Foundation Trust >> Formulary Item tablets
 
   
Cyproterone Acetate
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Amber
Royal Berkshire NHS Foundation Trust >> Formulary Item tablets
 
   
Flutamide (Drogenil®)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Amber
Royal Berkshire NHS Foundation Trust >> Formulary Item tablets
 
   
Goserelin (Zoladex®,Zoladex® LA)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Amber
Royal Berkshire NHS Foundation Trust >> Formulary Item 3.6mg implant only)
 
   
 ....
 Non Formulary Items
Buserelin  (Suprefact®)

View adult BNF View SPC online View childrens BNF Track Changes
Non Formulary
Amber
Royal Berkshire NHS Foundation Trust>> NON - Formulary Item - contact pharmacy for advice
 
Triptorelin  (Decapeptyl® SR, Gonapeptyl Depot®)

View adult BNF View SPC online View childrens BNF Track Changes
Non Formulary
Amber
Royal Berkshire NHS Foundation Trust>> NON - Formulary Item - contact pharmacy for advice
 
  
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
SMC
Scottish Medicines Consortium
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

Amber

Medicines that should be initiated or recommended by a specialist for continuation in primary care. The specialist must notify the primary care provider that the prescribing responsibility has been transferred. Where applicable, shared care protocols will be agreed and must be adhered to. The shared care protocol must have been agreed by the relevant secondary care trust Drugs and Therapeutics Committee(s)(DTC) and approved by Berkshire West APC.   

Brown

Drugs that have been reviewed and not recommended for prescribing. These drugs are not considered a cost effective use of scarce NHS resources. There may be individual patient specific or clinical reasons why a drug deemed low priority may be suitable for a particular patient. This is for the GP to condsider, weighing up the reasons against his/her allocated CCG budget. Where the decision is made to prescribe a low priority drug, detailed documentation must be included within the patients' notes for audit purposes. *Please note that low priority drug requests are unsuitable for the Case Review Committee and therefore should not be sent to this committee.   

Green

Medicines suitable for routine use and can be prescribed within primary care within their licensed indication in accordance with the BNF or other recognised national formulary. Primary care prescribers take full responsibility for prescribing  

Red

Medicines which should be prescribed by specialists only  

netFormulary